Wright Medical Group Inc
How Does Medtronic’s Restorative Therapies & Diabetes Group Look?
Medtronic’s Restorative Therapies Group consists of Spine, Brain, Specialty and Pain therapies.
Zimmer Biomet Holdings: Revenue Trends ahead of Its Q3 Earnings
Zimmer Biomet (ZBH) plans to release its Q3 earnings on October 26. Analysts expect ZBH to generate third-quarter revenues of $1.8 billion.
Profit Booking Leaves the iShares US Medical Devices ETF (IHI) in the Red
On May 19, markets declined, with the SPDR S&P 500 ETF dropping by 0.3% and the iShares US Medical Devices ETF (IHI) declining by 0.8%.
What Could Help Zimmer Biomet Regain Lost Market Share?
Some recent launches that might improve Zimmer Biomet’s market share include the modular XtraFix External Fixation system, a device for trauma patients that helps save time and cost.
Zimmer Biomet’s Competition in the Hip Implant Market
Zimmer Biomet (ZBH) is one of the leading hip implant providers in the United States, with approximately 31% market share.
Becton, Dickinson and Company’s 1Q16 Results: Major Influences
The majority of Becton, Dickinson and Company’s sales are generated from international markets and the company’s strong presence in the United States.
Analyzing Cost Structure for Medical Device Companies
As per the US Census, spending on medical devices in the US has been constant for over a decade between 2005 to 2015.
Assessing Medtronic’s Marketing and Sales Strategy in 2015
To extend cost-effective, high-quality medical devices and therapies, Medtronic aims to organize its marketing and sales teams around physician preferences.
Key Regulations that Affect Medical Device Companies
The US Food and Drug Administration’s Center for Devices for Radiological Health (or USFDA/CDRH) regulates the medical device industry in the United States.